Alfadel Alshaibani

Internal Medicine
1215 Lee St
Charlottesville, VA 22908

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications

Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study.

Real-world outcomes of Axicabtagene Ciloleucel CAR-T therapy in large B-cell lymphoma: a single-center observational study.

Journal: Cytotherapy
Published: October 21, 2025

Anaphylaxis During CAR T-Cell Infusion in an HIV-Positive Patient With High-Grade B-Cell Lymphoma: A Case Report and Literature Review.

Anaphylaxis During CAR T-Cell Infusion in an HIV-Positive Patient With High-Grade B-Cell Lymphoma: A Case Report and Literature Review.

Journal: EJHaem
Published: September 06, 2025

Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.

Transplant outcomes in adolescents and young adults with Philadelphia-positive B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: August 28, 2025

Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East.

Prognostic Factors and Real-World Outcomes in Adolescents and Young Adults (AYA) With Philadelphia-Negative Acute Lymphoblastic Leukemia (ALL) Treated With the AYA-15 Protocol: A Retrospective Cohort Study From a Tertiary Care Referral Center in the Middle East.

Journal: Clinical lymphoma, myeloma & leukemia
Published: June 05, 2025

Programmed death inhibitors in CNS B-cell lymphoma: A literature review.

Programmed death inhibitors in CNS B-cell lymphoma: A literature review.

Journal: Blood reviews
Published: June 02, 2025

Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east.

Outcomes of adolescent and young adult (AYA) patients with relapsed/refractory B-cell acute lymphoblastic leukemia treated with tisagenlecleucel, real world evidence from the middle east.

Journal: Cytotherapy
Published: May 15, 2025

Minimal Residual Disease Testing for Diffuse Large B Cell Lymphoma.

Minimal Residual Disease Testing for Diffuse Large B Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: March 14, 2025

Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience.

Outcomes of human leukocyte antigen matched sibling transplant from consanguineous versus non-consanguineous parents, a single center experience.

Journal: Bone marrow transplantation
Published: February 10, 2025

Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

Outcomes of Adolescent LBCL Patients Treated With Adult Type Chemotherapy: A Single Center Experience.

Journal: Clinical lymphoma, myeloma & leukemia
Published: January 18, 2025

Building simplified cancer subtyping and prediction models with glycan gene signatures.

Building simplified cancer subtyping and prediction models with glycan gene signatures.

Journal: Cell reports methods
Published: October 21, 2024

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients.

Journal: Annals of Saudi medicine
Published: April 14, 2024

Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.

Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.

Journal: Transplantation and cellular therapy
Published: November 22, 2023
Showing 1-12 of 30

Last Updated: 09/26/2026